Christopher Codispoti to Combined Modality Therapy
This is a "connection" page, showing publications Christopher Codispoti has written about Combined Modality Therapy.
Connection Strength
0.157
-
Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case. Ann Allergy Asthma Immunol. 2019 09; 123(3):311-312.
Score: 0.157
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.